Emmy and Tony award-winning actress and singer Kristin Chenoweth is kicking off  Allergan’s Rhofade "Less Red, More You" campaign.

Chenoweth, who has rosacea, will begin a nationwide conversation about the condition while raising awareness for RHOFADE (oxymetazoline HCl) cream, 1%, a new product indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.

“As a performer who is constantly on stage or in front of the camera, it's important that I take care of my skin, but unfortunately, persistent facial redness from rosacea is something I've struggled with every day for years," says Chenoweth in a news release. "I've been searching for a product that, with daily use, can help keep my redness in check. Recently, my dermatologist recommended something new. She gave me RHOFADE cream, a treatment I use once-a-day, every day that helps reduce my redness all-day, through 12 hours so I see less red and more me."

In two clinical trials, once-daily application of RHOFADE cream was proven to reduce persistent facial erythema associated with rosacea through 12 hours on day 29. Results seen in 12-18 percent of people using RHOFADE cream vs 5-9 percent of people using vehicle cream. The most common adverse reactions for RHOFADE were application site dermatitis, worsening inflammatory lesions of rosacea, application site pruritus, application site erythema, and application site pain.